acetylcysteine and quinoxalines

acetylcysteine has been researched along with quinoxalines in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (7.14)	18.2507
2000's	9 (64.29)	29.6817
2010's	4 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Funato, H; Kohsaka, S; Mochizuki, H; Shimojo, M; Takasugi, K; Yamamoto, I	1
Anfossi, G; Cavalot, F; Massucco, P; Mattiello, L; Russo, I; Trovati, M	1
Bendhack, LM; Ceron, PI; Cremonez, DC; Tedesco, AC	1
Li, H; Tian, H; Zhang, G; Zhang, Q	2
Diallo, AS; Lobysheva, I; Muller, B; Sarr, M; Schini-Kerth, VB; Stoclet, JC	1
Fukushima, S; Hayashi, S; Kinoshita, A; Morimura, K; Nishikawa, T; Nishikawa-Ogawa, M; Wanibuchi, H; Yano, Y	1
Chen, QZ; Gao, PJ; Guo, SJ; Han, WQ; Wu, LY; Zhu, DL	1
Chen, SD; Ding, JQ; Hong, Z; Pan, J; Sheng, CY; Wang, G; Xiao, Q; Yang, HQ	1
Gul, M; Imrek, S; Ozdemir, G; Tolun, FI	1
Costa-Campos, L; Elisabetsky, E; Garcia, CR; Linck, VM; Pilz, LK	1
Baker, NL; Carpenter, MJ; Froeliger, BE; Gipson, CD; Gray, KM; Kalivas, PW; McClure, EA; Roper, AP	1
Kasukabe, T; Kumakura, S; Yamaguchi, Y	1
Avdonin, PP; Avdonin, PV; Goncharov, NV; Mironova, GY; Nadeev, AD; Zharkikh, IL	1

Trials

1 trial(s) available for acetylcysteine and quinoxalines

Article	Year
An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. The American journal of drug and alcohol abuse, 2015, Volume: 41, Issue:1 Topics: Acetylcysteine; Administration, Oral; Adolescent; Adult; Aged; Benzazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline	2015

Article

Year

An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers.

The American journal of drug and alcohol abuse, 2015, Volume: 41, Issue:1

Topics: Acetylcysteine; Administration, Oral; Adolescent; Adult; Aged; Benzazepines; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline

2015

Other Studies

13 other study(ies) available for acetylcysteine and quinoxalines

Article	Year
Neuroprotective action of a novel compound--M50463--in primary cultured neurons. Brain research, 1999, Jan-02, Volume: 815, Issue:1 Topics: Acetylcysteine; Animals; Antihypertensive Agents; Batrachotoxins; Binding Sites; Binding, Competitive; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Death; Cells, Cultured; Culture Media, Serum-Free; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fetus; Glutamic Acid; Indoles; Neurons; Neuroprotective Agents; Neurotoxins; Nicardipine; Nitroprusside; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Sodium Channels; Thiazoles; Veratrine; Vitamin E	1999
N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. European journal of clinical investigation, 2001, Volume: 31, Issue:5 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Acetylcysteine; Adenosine Diphosphate; Adult; Calcimycin; Cell Membrane Permeability; Collagen; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Humans; Ionomycin; Male; omega-N-Methylarginine; Oxadiazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinones; Quinoxalines	2001
The relaxation induced by S-nitroso-glutathione and S-nitroso-N-acetylcysteine in rat aorta is not related to nitric oxide production. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:2 Topics: Acetylcysteine; Animals; Aorta, Thoracic; Endothelium, Vascular; Enzyme Inhibitors; Glutathione; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroso Compounds; Oxadiazoles; Phenylephrine; Potassium Channel Blockers; Potassium Chloride; Quinoxalines; Rats; Rats, Wistar; Ryanodine; S-Nitrosoglutathione; Thapsigargin; Vasoconstrictor Agents; Vasodilation	2001
Antioxidant NAC and AMPA/KA receptor antagonist DNQX inhibited JNK3 activation following global ischemia in rat hippocampus. Neuroscience research, 2003, Volume: 46, Issue:2 Topics: Acetylcysteine; Animals; Brain Ischemia; Calcium Channel Blockers; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Immunoblotting; Ketamine; Male; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinases; Nifedipine; Protein Transport; Protein-Tyrosine Kinases; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Time Factors	2003
Antioxidant N-acetylcysteine and AMPA/KA receptor antagonist DNQX inhibited mixed lineage kinase-3 activation following cerebral ischemia in rat hippocampus. Neuroscience research, 2003, Volume: 47, Issue:1 Topics: Acetylcysteine; Animals; Antioxidants; Brain Ischemia; Enzyme Activation; Excitatory Amino Acid Antagonists; Hippocampus; Male; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase Kinase Kinase 11; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid	2003
Formation of releasable NO stores by S-nitrosoglutathione in arteries exhibiting tolerance to glyceryl-trinitrate. European journal of pharmacology, 2005, Apr-18, Volume: 513, Issue:1-2 Topics: Acetylcysteine; Analysis of Variance; Animals; Aorta, Thoracic; Cyclic GMP; Diethylamines; Dose-Response Relationship, Drug; Drug Tolerance; In Vitro Techniques; Male; Nitric Oxide; Nitrogen Oxides; Nitroglycerin; Norepinephrine; Oxadiazoles; Quinoxalines; Rats; Rats, Wistar; S-Nitrosoglutathione; Superoxide Dismutase; Thionucleotides; Vasoconstriction; Vasodilation	2005
N-acetylcysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage. Carcinogenesis, 2006, Volume: 27, Issue:5 Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Carcinogens; Cell Proliferation; Cysteine; Down-Regulation; Glutathione Transferase; Insulin-Like Growth Factor I; Liver Neoplasms; Nitric Oxide Synthase Type II; Placenta; Quinoxalines; Rats; Silver Staining; Time Factors	2006
N-acetylcysteine-induced vasodilation involves voltage-gated potassium channels in rat aorta. Life sciences, 2009, May-22, Volume: 84, Issue:21-22 Topics: Acetylcysteine; Animals; Calcium; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Guanylate Cyclase; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Oxadiazoles; Phenylephrine; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Kinase C; Quinoxalines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Vasoconstrictor Agents; Vasodilation	2009
Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease. Neurochemistry international, 2009, Volume: 54, Issue:7 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcysteine; Animals; Blotting, Western; Cell Nucleus; Dopamine; Dopamine Agents; Enzyme Activation; Excitatory Amino Acid Antagonists; Immunohistochemistry; Immunoprecipitation; Ketamine; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 10; Neostriatum; Neurons; Parkinson Disease; Protein Transport; Quinoxalines; Tyrosine 3-Monooxygenase	2009
Retinal oxidative stress induced by intraocular hypertension in rats may be ameliorated by brimonidine treatment and N-acetyl cysteine supplementation. Journal of glaucoma, 2009, Volume: 18, Issue:9 Topics: Acetylcysteine; Animals; Brimonidine Tartrate; Catalase; Disease Models, Animal; Drug Therapy, Combination; Glutathione Peroxidase; Hyaluronic Acid; Intraocular Pressure; Male; Malondialdehyde; Nitric Oxide; Ocular Hypertension; Oxidative Stress; Quinoxalines; Rats; Rats, Sprague-Dawley; Retinal Diseases; Tonometry, Ocular	2009
AMPA glutamate receptors mediate the antidepressant-like effects of N-acetylcysteine in the mouse tail suspension test. Behavioural pharmacology, 2012, Volume: 23, Issue:2 Topics: Acetylcysteine; alpha-Methyltyrosine; Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fenclonine; Hindlimb Suspension; Locomotion; Male; Mice; Mice, Inbred Strains; N-Methylaspartate; Quinoxalines; Receptors, AMPA	2012
Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis. International journal of oncology, 2018, Volume: 52, Issue:3 Topics: Acetylcysteine; Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Line, Tumor; Cyclohexylamines; Deferoxamine; Dioxolanes; Diterpenes; Drug Synergism; Fibroblasts; Humans; Iron; Mice; Pancreatic Neoplasms; Phenylenediamines; Quinoxalines; Reactive Oxygen Species; Spiro Compounds; Sulfasalazine	2018
Enhancement by Hydrogen Peroxide of Calcium Signals in Endothelial Cells Induced by 5-HT1B and 5-HT2B Receptor Agonists. Oxidative medicine and cellular longevity, 2019, Volume: 2019 Topics: Acetylcysteine; Benzoxazoles; Calcium; Calcium Signaling; Fluorescence; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Indoles; Quinoxalines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Thiophenes; Triazoles; Vanadates	2019